Description: A large percentage of patients with gastrointestinal tumors (such as pancreatic, liver, gastric, colorectal tumors) and some other malignancies have been shown to have elevated serum CA 19-9 levels. Serum CA 19-9 levels may be useful for monitoring disease activity or predicting relapse following treatment. CA 19-9 should not be used as a screening test.
Alternative Name(s): Carbohydrate Antigen 19-9; CA 19-9
A significant deviation from the normal range may require further evaluation by your physician.
Description: This test is used to monitor gastrointestinal, pancreatic, liver, and colorectal malignancies. A significant deviation from the normal range may require further evaluation by your physician.